RESUMEN
OBJECTIVE: This study aims to assess the clinical efficacy and safety of CHF-II in combination with RG for treating AKI on CKD (A on C), and to explore potential therapeutic mechanisms through lipidomics analysis. METHODS: 98 patients were enrolled and randomly assigned to the RG or RG + CHF groups. Both groups received RG therapy, with RG + CHF group additionally receiving CHF-II treatment over a duration of two weeks. Evaluation endpoints included changes in renal function, blood lipid profiles, urinary AKI biomarkers, and TCM symptoms before and after treatment. Serum samples were collected for lipid metabolite analysis. RESULTS: The total clinical effective rate in RG + CHF group was 73.5%, and that of RG group was 40.8%. TCM syndrome scores in RG + CHF group showed a more pronounced decrease (p < 0.05). Scr, BUN, and UA levels decreased while eGFR levels increased in both groups (p < 0.05), with a greater magnitude of change observed in the RG + CHF group. Urinary AKI biomarkers decreased more in RG + CHF group (p < 0.05). No serious adverse events occurred during the trial. 58 different lipid metabolites and 48 lipid biomarkers were identified. According to the KEGG database, the possible metabolic pathways involved triglyceride metabolic pathway and fat digestion and absorption metabolic pathways. CONCLUSION: CHF-II effectively alleviated kidney injury and improved TCM syndrome scores in patients with A on C. Lipid differential metabolites could serve as diagnostic indicators for AKI in patients with CKD. The possible metabolic pathways might be implicated in therapeutic action of CHF-II in the prevention and treatment of patients with A on C.
Asunto(s)
Lesión Renal Aguda , Biomarcadores , Medicamentos Herbarios Chinos , Lipidómica , Insuficiencia Renal Crónica , Humanos , Masculino , Lesión Renal Aguda/etiología , Lesión Renal Aguda/tratamiento farmacológico , Femenino , Persona de Mediana Edad , Medicamentos Herbarios Chinos/uso terapéutico , Insuficiencia Renal Crónica/complicaciones , Insuficiencia Renal Crónica/tratamiento farmacológico , Anciano , Biomarcadores/sangre , Biomarcadores/orina , Adulto , Lípidos/sangre , Tasa de Filtración Glomerular/efectos de los fármacos , Resultado del Tratamiento , Medicina Tradicional China/métodosRESUMEN
Income inequality and carbon emission efficiency are the primary issues that need to be addressed to achieve UN sustainable development goals. However, research on the relationship between income inequality and carbon emission efficiency has not received enough attention. To more comprehensively understand how income inequality affects carbon emission efficiency, and how aging and economic growth affect the relationship between income inequality and carbon emissions efficiency, fixed effect regression estimation and threshold effect regression estimation approaches are developed based on panel data of 139 countries from 1998 to 2018. The results show that: (i) there is an inhibitory effect of income inequality on the improvement of carbon emission efficiency; (ii) under the influence of aging, there is a U-shaped relationship between income inequality and carbon emission efficiency, that is, income inequality has an inhibitory effect on the improvement of carbon emission efficiency before promoting it; (iii) along with the rapid economic growth, the inhibitory effect of income inequality on carbon emission efficiency increases, that is, there is an inverted U-shaped relationship between income inequality and carbon emission efficiency. Finally, we combine the changes in spatial and temporal distributions to propose corresponding policy recommendations.